JF
CLPT icon

Jump Financial’s ClearPoint Neuro CLPT Stock Holding History

Jump Financial’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Sell
10,993
-407
-4% -$5.08K ﹤0.01% 1855
2026
Q1 		$104K Buy
+11,400
New +$144K ﹤0.01% 1748
2025
Q4 		– Sell
-12,226
Closed -$266K – 1978
2025
Q3 		$266K Buy
+12,226
New +$144K ﹤0.01% 1543
2024
Q4 		– Sell
-24,322
Closed -$273K – 1693
2024
Q3 		$273K Buy
24,322
+7,376
+44% +$70.6K 0.01% 1352
2024
Q2 		$91.3K Buy
+16,946
New +$98.1K ﹤0.01% 1653
2023
Q1 		– Sell
-14,312
Closed -$121K – 1649
2022
Q4 		$121K Buy
14,312
+877
+7% +$8.31K 0.01% 1396
2022
Q3 		$139K Buy
+13,435
New +$177K 0.01% 1407
2022
Q2 		– Sell
-15,800
Closed -$164K – 1663
2022
Q1 		$164K Sell
15,800
-5,600
-26% -$51K 0.01% 1347
2021
Q4 		$240K Buy
+21,400
New +$320K 0.02% 1012
2021
Q3 		– Sell
-17,982
Closed -$343K – 1145
2021
Q2 		$343K Sell
17,982
-15
-0.1% -$290 0.03% 613
2021
Q1 		$380K Buy
+17,997
New +$385K 0.04% 511

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Jump Financial's CLPT Position: Q2 2026 in Review

Jump Financial reduced its ClearPoint Neuro (CLPT) stake by 3.6% in Q2 2026, selling an estimated $5.08K and leaving 10,993 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Jump Financial first reported a position in CLPT in Q1 2021 and has held it in 11 quarters since. The position peaked at $380K in Q1 2021. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Jump Financial held 10,993 shares of ClearPoint Neuro worth $196K as of Q2 2026.
  • Jump Financial sold 407 ClearPoint Neuro shares in Q2 2026, an estimated $5.08K.
  • ClearPoint Neuro made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1855 holding.
  • Jump Financial first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 11 quarters since.
  • Jump Financial's ClearPoint Neuro position peaked at $380K in Q1 2021.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.